Dataset Information


HMVEC cells treated with vascular endothelial growth factor, anthrax edema toxin, and an Epac activator

ABSTRACT: Human microvascular endothelial cells (HMVEC) treated with vascular endothelial growth factor (VEGF), Antrhax Edema Toxin (ET), or the Epac activator, 8-pCPT-2'-O-Me-cAMP (8CPT) Human microvascular endothelial cells (HMVEC) were treated with VEGF alone or VEGF in combination with either the the Epac-specific cAMP-mimetic, 8-pCPT-2'-O-Me-cAMP (8CPT), or anthrax edema toxin (ET), an adenylyl cyclase. ET or 8CPT can inhibit VEGF-mediated chemotaxis and angiogenesis. The goal of the study was to identify genes regulated by cAMP production (ET) or by activation of Epac/Rap (8CPT) that may mitigate the effects of VEGF treatment. Overall design: Gene expression was measured 4 hours after treatment with VEGF, VEGF + 8CPT, VEGF + ET or mock treatment. Each sample contained one replicate.

INSTRUMENT(S): [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

ORGANISM(S): Homo sapiens  

SUBMITTER: Robert C Doebele  

PROVIDER: GSE17777 | GEO | 2009-08-25



Dataset's files

Action DRS
GSE17777_RAW.tar Raw
filelist.txt Txt
Items per page:
1 - 2 of 2

Similar Datasets

2009-09-13 | E-GEOD-17777 | ArrayExpress
1000-01-01 | S-EPMC3277462 | BioStudies
2009-01-01 | S-EPMC2633058 | BioStudies
2007-09-28 | GSE9184 | GEO
2008-06-16 | E-GEOD-9184 | ArrayExpress
2018-01-01 | S-EPMC5875723 | BioStudies
2018-01-01 | S-EPMC5991715 | BioStudies
2013-01-01 | S-EPMC3664343 | BioStudies
1000-01-01 | S-EPMC5767874 | BioStudies
2021-09-29 | GSE184619 | GEO